Literature DB >> 20305680

Protective effects of prostaglandin E1 on human umbilical vein endothelial cell injury induced by hydrogen peroxide.

Wen-tong Fang1, Hong-jian Li, Liao-sheng Zhou.   

Abstract

AIM: To investigate the protective effects of prostaglandin E(1) (PGE(1)) against H(2)O(2)-induced oxidative damage on human umbilical vein endothelial cells (HUVECs).
METHODS: HUVECs were pretreated with PGE(1) (0.25, 0.50, and 1.00 micromol/L) for 24 h and exposed to H(2)O(2) (200 micromol/L) for 12 h, and cell viability was measured by the MTT assay. LDH, NO, SOD, GSH-Px, MDA, ROS, and apoptotic percentage were determined. eNOS expression was measured by Western blotting and real-time PCR.
RESULTS: PGE(1) (0.25-1.00 micromol/L) was able to markedly restore the viability of HUVECs under oxidative stress, and scavenged intracellular reactive oxygen species induced by H(2)O(2). PGE(1) also suppressed the production of lipid peroxides, such as MDA, restored the activities of endogenous antioxidants including SOD and GSH-Px, and inhibited cell apoptosis. In addition, PGE(1) significantly increased NO content, eNOS protein, and mRNA expression.
CONCLUSION: PGE(1) effectively protected endothelial cells against oxidative stress induced by H(2)O(2), an activity that might depend on the up-regulation of NO expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20305680      PMCID: PMC4007667          DOI: 10.1038/aps.2010.23

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  36 in total

1.  Prostaglandin E(1) does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass grafting.

Authors:  G J Locker; M Grimm; H Losert; B Stoiser; J Kofler; S Knapp; A Wilfing; P Knoebl; S Kapiotis; M Czerny; M Muhm; M Hiesmayr; M Frass
Journal:  J Clin Anesth       Date:  2000-08       Impact factor: 9.452

2.  Hemostasis and fibrinolysis in patients with intermittent claudication: effects of prostaglandin E1.

Authors:  C Weiss; S Regele; T Velich; P Bärtsch; T Weiss
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2000-11       Impact factor: 4.006

3.  Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase.

Authors:  B J Michell; T Tiganis; D Stapleton; F Katsis; D A Power; A T Sim; B E Kemp
Journal:  J Biol Chem       Date:  2001-04-05       Impact factor: 5.157

Review 4.  Prostanoid receptor subtypes.

Authors:  Kazuhito Tsuboi; Yukihiko Sugimoto; Atsushi Ichikawa
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

5.  Regulation of eNOS expression in brain endothelial cells by perinuclear EP(3) receptors.

Authors:  Fernand Gobeil; Isabelle Dumont; Anne Marilise Marrache; Alejandro Vazquez-Tello; Sylvie G Bernier; Daniel Abran; Xin Hou; Martin H Beauchamp; Christiane Quiniou; Asmaa Bouayad; Sanaa Choufani; Mousumi Bhattacharya; Stephane Molotchnikoff; Alfredo Ribeiro-Da-Silva; Daya R Varma; Ghassan Bkaily; Sylvain Chemtob
Journal:  Circ Res       Date:  2002-04-05       Impact factor: 17.367

6.  Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways.

Authors:  Kazuo Niwano; Masashi Arai; Koichi Tomaru; Tsuyoshi Uchiyama; Yoshio Ohyama; Masahiko Kurabayashi
Journal:  Circ Res       Date:  2003-08-14       Impact factor: 17.367

7.  Prostaglandin E(1) protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation.

Authors:  Hong Yang; Pietro Majno; Philippe Morel; Christian Toso; Fréderic Triponez; José Oberholzer; Gilles Mentha; Jinning Lou
Journal:  Microvasc Res       Date:  2002-07       Impact factor: 3.514

8.  Prostaglandin E1 improves endothelial function in critical limb ischemia.

Authors:  Simona Marchesi; Leonella Pasqualini; Rita Lombardini; Gaetano Vaudo; Graziana Lupattelli; Matteo Pirro; Giuseppe Schillaci; Elmo Mannarino
Journal:  J Cardiovasc Pharmacol       Date:  2003-02       Impact factor: 3.105

9.  A synthetic analog of prostaglandin E(1) prevents the production of reactive oxygen species in the intestinal mucosa of methotrexate-treated rats.

Authors:  Feng Gao; Toshiharu Horie
Journal:  Life Sci       Date:  2002-07-19       Impact factor: 5.037

10.  Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease.

Authors:  Mohammad Reza Mehrabi; Nermin Serbecic; Forouzan Tamaddon; Christoph Kaun; Kurt Huber; Richard Pacher; Thomas Wild; Gerhard Mall; Johann Wojta; Helmut-D Glogar
Journal:  Cardiovasc Res       Date:  2002-11       Impact factor: 10.787

View more
  17 in total

1.  The protective role of 5-HMF against hypoxic injury.

Authors:  Ming-Ming Li; Li-Ying Wu; Tong Zhao; Lei Xiong; Xin Huang; Zhao-Hui Liu; Xue-Lai Fan; Cheng-Rong Xiao; Yue Gao; Yun-Bao Ma; Ji-Jun Chen; Ling-Ling Zhu; Ming Fan
Journal:  Cell Stress Chaperones       Date:  2010-11-06       Impact factor: 3.667

2.  Edaravone attenuates experimental asthma in mice through induction of HO-1 and the Keap1/Nrf2 pathway.

Authors:  Yuting Pan; Weihao Li; Ying Feng; Jing Xu; Huifang Cao
Journal:  Exp Ther Med       Date:  2019-12-19       Impact factor: 2.447

3.  Prostaglandin E1 protects coronary microvascular function via the glycogen synthase kinase 3β-mitochondrial permeability transition pore pathway in rat hearts subjected to sodium laurate-induced coronary microembolization.

Authors:  Houyong Zhu; Yu Ding; Xiaoqun Xu; Meiya Li; Yangliang Fang; Beibei Gao; Hengyi Mao; Guoxin Tong; Liang Zhou; Jinyu Huang
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

4.  Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases.

Authors:  Kelly J Ledford; Nikki Murphy; Frank Zeigler; Ronnda L Bartel; Ross Tubo
Journal:  Stem Cell Res Ther       Date:  2015-03-13       Impact factor: 6.832

Review 5.  Switching off key signaling survival molecules to switch on the resolution of inflammation.

Authors:  Denise Alves Perez; Juliana Priscila Vago; Rayssa Maciel Athayde; Alesandra Corte Reis; Mauro Martins Teixeira; Lirlândia Pires Sousa; Vanessa Pinho
Journal:  Mediators Inflamm       Date:  2014-07-17       Impact factor: 4.711

6.  Sinapic acid prevents hypertension and cardiovascular remodeling in pharmacological model of nitric oxide inhibited rats.

Authors:  Thangarasu Silambarasan; Jeganathan Manivannan; Mani Krishna Priya; Natarajan Suganya; Suvro Chatterjee; Boobalan Raja
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

7.  Induction of eosinophil apoptosis by hydrogen peroxide promotes the resolution of allergic inflammation.

Authors:  A C Reis; A L Alessandri; R M Athayde; D A Perez; J P Vago; T V Ávila; T P T Ferreira; A C S de Arantes; D de Sá Coutinho; M A Rachid; L P Sousa; M A Martins; G B Menezes; A G Rossi; M M Teixeira; V Pinho
Journal:  Cell Death Dis       Date:  2015-02-12       Impact factor: 8.469

8.  Effects of cryopreservation on excretory function, cellular adhesion molecules and vessel lumen formation in human umbilical vein endothelial cells.

Authors:  Guoping Cai; Binbin Lai; Huaxing Hong; Peng Lin; Weifu Chen; Zhong Zhu; Haixiao Chen
Journal:  Mol Med Rep       Date:  2017-05-31       Impact factor: 2.952

9.  Prostaglandin E₁ protects bone marrow-derived mesenchymal stem cells against serum deprivation-induced apoptosis.

Authors:  Kuan Zeng; Bao Ping Deng; Hui-Qi Jiang; Meng Wang; Ping Hua; Hong-Wu Zhang; Yu-Bin Deng; Yan-Qi Yang
Journal:  Mol Med Rep       Date:  2015-08-05       Impact factor: 2.952

10.  Sphingosine-1-phosphate promotes the differentiation of adipose-derived stem cells into endothelial nitric oxide synthase (eNOS) expressing endothelial-like cells.

Authors:  Divya Arya; Shaohua Chang; Paul DiMuzio; Jeffrey Carpenter; Thomas N Tulenko
Journal:  J Biomed Sci       Date:  2014-06-04       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.